APA (7th ed.) Citation

Hackert, T., Sachsenmaier, M., Hinz, U., Schneider, L., Michalski, C., Springfeld, C., . . . Büchler, M. W. (2016). Locally advanced pancreatic cancer: Neoadjuvant therapy with folfirinox results in resectability in 60% of the patients. Annals of surgery, 264(3), . https://doi.org/10.1097/SLA.0000000000001850

Chicago Style (17th ed.) Citation

Hackert, Thilo, et al. "Locally Advanced Pancreatic Cancer: Neoadjuvant Therapy with Folfirinox Results in Resectability in 60% of the Patients." Annals of Surgery 264, no. 3 (2016). https://doi.org/10.1097/SLA.0000000000001850.

MLA (9th ed.) Citation

Hackert, Thilo, et al. "Locally Advanced Pancreatic Cancer: Neoadjuvant Therapy with Folfirinox Results in Resectability in 60% of the Patients." Annals of Surgery, vol. 264, no. 3, 2016, https://doi.org/10.1097/SLA.0000000000001850.